ImClone (IMCL) Tells Bristol-Myers (BMY) $60/Sh Offer Is Inadequate; Says $70/Sh Offer On the Table From Another
Tweet Send to a Friend
ImClone Systems (NASDAQ: IMCL) Chairman, Carl Icahn, stated that the Special Committee of ImClone's Board of Directors has informed Bristol-Myers ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
